Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes

Position paper of an International Consortium and the European LeukemiaNet Working Group

Arjan A. Van De Loosdrecht, Robin Ireland, Wolfgang Kern, Matteo G. Della Porta, Canan Alhan, Jan Sebastian Balleisen, Peter Bettelheim, David T. Bowen, Kate Burbury, Lisa Eidenschink, Mario Cazzola, Spencer S C Chu, Matthew Cullen, Jevon A. Cutler, Angelika M. Dräger, Jean Feuillard, Pierre Fenaux, Patricia Font, Ulrich Germing, Detlef Haase & 31 others Eva Hellström-Lindberg, Ulrika Johansson, Shahram Kordasti, Michael R. Loken, Luca Malcovati, Jeroen G. Te Marvelde, Sergio Matarraz, Timothy Milne, Bijan Moshaver, Ghulam J. Mufti, Veselka Nikolova, Kiyoyuki Ogata, Uta Oelschlaegel, Alberto Orfao, Gert J. Ossenkoppele, Anna Porwit, Uwe Platzbecker, Frank Preijers, Katherina Psarra, Stephen J. Richards, Dolores Subirá, John F. Seymour, Vicky Tindell, Teresa Vallespi, Peter Valent, Vincent H J Van Der Velden, Denise A. Wells, Theo M. De Witte, Florian Zettl, Marie C. Béné, Theresia M. Westers

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

An international working group within the European LeukemiaNet gathered, aiming to determine the role of flow cytometry (FC) in myelodysplastic syndromes (MDS). It was agreed that FC has a substantial application in disease characterization, diagnosis and prognosis. FC may also be useful in predicting treatment responses and monitoring novel and standard therapeutic regimens. In this article the rationale is discussed that flow cytometry should be integrated as a part of diagnostic and prognostic scoring systems in MDS.

Original languageEnglish
Pages (from-to)472-475
Number of pages4
JournalLeukemia and Lymphoma
Volume54
Issue number3
DOIs
Publication statusPublished - Mar 2013

Fingerprint

Myelodysplastic Syndromes
Flow Cytometry
Therapeutics

Keywords

  • Consensus
  • ELN
  • Flow cytometry
  • Myelodysplastic syndromes

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research

Cite this

Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes : Position paper of an International Consortium and the European LeukemiaNet Working Group. / Van De Loosdrecht, Arjan A.; Ireland, Robin; Kern, Wolfgang; Della Porta, Matteo G.; Alhan, Canan; Balleisen, Jan Sebastian; Bettelheim, Peter; Bowen, David T.; Burbury, Kate; Eidenschink, Lisa; Cazzola, Mario; Chu, Spencer S C; Cullen, Matthew; Cutler, Jevon A.; Dräger, Angelika M.; Feuillard, Jean; Fenaux, Pierre; Font, Patricia; Germing, Ulrich; Haase, Detlef; Hellström-Lindberg, Eva; Johansson, Ulrika; Kordasti, Shahram; Loken, Michael R.; Malcovati, Luca; Te Marvelde, Jeroen G.; Matarraz, Sergio; Milne, Timothy; Moshaver, Bijan; Mufti, Ghulam J.; Nikolova, Veselka; Ogata, Kiyoyuki; Oelschlaegel, Uta; Orfao, Alberto; Ossenkoppele, Gert J.; Porwit, Anna; Platzbecker, Uwe; Preijers, Frank; Psarra, Katherina; Richards, Stephen J.; Subirá, Dolores; Seymour, John F.; Tindell, Vicky; Vallespi, Teresa; Valent, Peter; Van Der Velden, Vincent H J; Wells, Denise A.; De Witte, Theo M.; Zettl, Florian; Béné, Marie C.; Westers, Theresia M.

In: Leukemia and Lymphoma, Vol. 54, No. 3, 03.2013, p. 472-475.

Research output: Contribution to journalArticle

Van De Loosdrecht, AA, Ireland, R, Kern, W, Della Porta, MG, Alhan, C, Balleisen, JS, Bettelheim, P, Bowen, DT, Burbury, K, Eidenschink, L, Cazzola, M, Chu, SSC, Cullen, M, Cutler, JA, Dräger, AM, Feuillard, J, Fenaux, P, Font, P, Germing, U, Haase, D, Hellström-Lindberg, E, Johansson, U, Kordasti, S, Loken, MR, Malcovati, L, Te Marvelde, JG, Matarraz, S, Milne, T, Moshaver, B, Mufti, GJ, Nikolova, V, Ogata, K, Oelschlaegel, U, Orfao, A, Ossenkoppele, GJ, Porwit, A, Platzbecker, U, Preijers, F, Psarra, K, Richards, SJ, Subirá, D, Seymour, JF, Tindell, V, Vallespi, T, Valent, P, Van Der Velden, VHJ, Wells, DA, De Witte, TM, Zettl, F, Béné, MC & Westers, TM 2013, 'Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: Position paper of an International Consortium and the European LeukemiaNet Working Group', Leukemia and Lymphoma, vol. 54, no. 3, pp. 472-475. https://doi.org/10.3109/10428194.2012.718341
Van De Loosdrecht, Arjan A. ; Ireland, Robin ; Kern, Wolfgang ; Della Porta, Matteo G. ; Alhan, Canan ; Balleisen, Jan Sebastian ; Bettelheim, Peter ; Bowen, David T. ; Burbury, Kate ; Eidenschink, Lisa ; Cazzola, Mario ; Chu, Spencer S C ; Cullen, Matthew ; Cutler, Jevon A. ; Dräger, Angelika M. ; Feuillard, Jean ; Fenaux, Pierre ; Font, Patricia ; Germing, Ulrich ; Haase, Detlef ; Hellström-Lindberg, Eva ; Johansson, Ulrika ; Kordasti, Shahram ; Loken, Michael R. ; Malcovati, Luca ; Te Marvelde, Jeroen G. ; Matarraz, Sergio ; Milne, Timothy ; Moshaver, Bijan ; Mufti, Ghulam J. ; Nikolova, Veselka ; Ogata, Kiyoyuki ; Oelschlaegel, Uta ; Orfao, Alberto ; Ossenkoppele, Gert J. ; Porwit, Anna ; Platzbecker, Uwe ; Preijers, Frank ; Psarra, Katherina ; Richards, Stephen J. ; Subirá, Dolores ; Seymour, John F. ; Tindell, Vicky ; Vallespi, Teresa ; Valent, Peter ; Van Der Velden, Vincent H J ; Wells, Denise A. ; De Witte, Theo M. ; Zettl, Florian ; Béné, Marie C. ; Westers, Theresia M. / Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes : Position paper of an International Consortium and the European LeukemiaNet Working Group. In: Leukemia and Lymphoma. 2013 ; Vol. 54, No. 3. pp. 472-475.
@article{feececd3793847b5810fc75301245549,
title = "Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes: Position paper of an International Consortium and the European LeukemiaNet Working Group",
abstract = "An international working group within the European LeukemiaNet gathered, aiming to determine the role of flow cytometry (FC) in myelodysplastic syndromes (MDS). It was agreed that FC has a substantial application in disease characterization, diagnosis and prognosis. FC may also be useful in predicting treatment responses and monitoring novel and standard therapeutic regimens. In this article the rationale is discussed that flow cytometry should be integrated as a part of diagnostic and prognostic scoring systems in MDS.",
keywords = "Consensus, ELN, Flow cytometry, Myelodysplastic syndromes",
author = "{Van De Loosdrecht}, {Arjan A.} and Robin Ireland and Wolfgang Kern and {Della Porta}, {Matteo G.} and Canan Alhan and Balleisen, {Jan Sebastian} and Peter Bettelheim and Bowen, {David T.} and Kate Burbury and Lisa Eidenschink and Mario Cazzola and Chu, {Spencer S C} and Matthew Cullen and Cutler, {Jevon A.} and Dr{\"a}ger, {Angelika M.} and Jean Feuillard and Pierre Fenaux and Patricia Font and Ulrich Germing and Detlef Haase and Eva Hellstr{\"o}m-Lindberg and Ulrika Johansson and Shahram Kordasti and Loken, {Michael R.} and Luca Malcovati and {Te Marvelde}, {Jeroen G.} and Sergio Matarraz and Timothy Milne and Bijan Moshaver and Mufti, {Ghulam J.} and Veselka Nikolova and Kiyoyuki Ogata and Uta Oelschlaegel and Alberto Orfao and Ossenkoppele, {Gert J.} and Anna Porwit and Uwe Platzbecker and Frank Preijers and Katherina Psarra and Richards, {Stephen J.} and Dolores Subir{\'a} and Seymour, {John F.} and Vicky Tindell and Teresa Vallespi and Peter Valent and {Van Der Velden}, {Vincent H J} and Wells, {Denise A.} and {De Witte}, {Theo M.} and Florian Zettl and B{\'e}n{\'e}, {Marie C.} and Westers, {Theresia M.}",
year = "2013",
month = "3",
doi = "10.3109/10428194.2012.718341",
language = "English",
volume = "54",
pages = "472--475",
journal = "Leukemia and Lymphoma",
issn = "1042-8194",
publisher = "Taylor and Francis Ltd.",
number = "3",

}

TY - JOUR

T1 - Rationale for the clinical application of flow cytometry in patients with myelodysplastic syndromes

T2 - Position paper of an International Consortium and the European LeukemiaNet Working Group

AU - Van De Loosdrecht, Arjan A.

AU - Ireland, Robin

AU - Kern, Wolfgang

AU - Della Porta, Matteo G.

AU - Alhan, Canan

AU - Balleisen, Jan Sebastian

AU - Bettelheim, Peter

AU - Bowen, David T.

AU - Burbury, Kate

AU - Eidenschink, Lisa

AU - Cazzola, Mario

AU - Chu, Spencer S C

AU - Cullen, Matthew

AU - Cutler, Jevon A.

AU - Dräger, Angelika M.

AU - Feuillard, Jean

AU - Fenaux, Pierre

AU - Font, Patricia

AU - Germing, Ulrich

AU - Haase, Detlef

AU - Hellström-Lindberg, Eva

AU - Johansson, Ulrika

AU - Kordasti, Shahram

AU - Loken, Michael R.

AU - Malcovati, Luca

AU - Te Marvelde, Jeroen G.

AU - Matarraz, Sergio

AU - Milne, Timothy

AU - Moshaver, Bijan

AU - Mufti, Ghulam J.

AU - Nikolova, Veselka

AU - Ogata, Kiyoyuki

AU - Oelschlaegel, Uta

AU - Orfao, Alberto

AU - Ossenkoppele, Gert J.

AU - Porwit, Anna

AU - Platzbecker, Uwe

AU - Preijers, Frank

AU - Psarra, Katherina

AU - Richards, Stephen J.

AU - Subirá, Dolores

AU - Seymour, John F.

AU - Tindell, Vicky

AU - Vallespi, Teresa

AU - Valent, Peter

AU - Van Der Velden, Vincent H J

AU - Wells, Denise A.

AU - De Witte, Theo M.

AU - Zettl, Florian

AU - Béné, Marie C.

AU - Westers, Theresia M.

PY - 2013/3

Y1 - 2013/3

N2 - An international working group within the European LeukemiaNet gathered, aiming to determine the role of flow cytometry (FC) in myelodysplastic syndromes (MDS). It was agreed that FC has a substantial application in disease characterization, diagnosis and prognosis. FC may also be useful in predicting treatment responses and monitoring novel and standard therapeutic regimens. In this article the rationale is discussed that flow cytometry should be integrated as a part of diagnostic and prognostic scoring systems in MDS.

AB - An international working group within the European LeukemiaNet gathered, aiming to determine the role of flow cytometry (FC) in myelodysplastic syndromes (MDS). It was agreed that FC has a substantial application in disease characterization, diagnosis and prognosis. FC may also be useful in predicting treatment responses and monitoring novel and standard therapeutic regimens. In this article the rationale is discussed that flow cytometry should be integrated as a part of diagnostic and prognostic scoring systems in MDS.

KW - Consensus

KW - ELN

KW - Flow cytometry

KW - Myelodysplastic syndromes

UR - http://www.scopus.com/inward/record.url?scp=84873396563&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84873396563&partnerID=8YFLogxK

U2 - 10.3109/10428194.2012.718341

DO - 10.3109/10428194.2012.718341

M3 - Article

VL - 54

SP - 472

EP - 475

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

SN - 1042-8194

IS - 3

ER -